Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 3 Interventional

Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia

ClinicalTrials.gov ID: NCT02670434

Public ClinicalTrials.gov record NCT02670434. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 5:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02670434
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 3
Lead sponsor
Kowa Research Institute, Inc.
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • NK-104-CR Drug
  • Placebo Drug
  • Livalo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2015
Primary completion
Jun 30, 2017
Completion
Sep 30, 2017
Last update posted
May 9, 2021

2016 – 2017

United States locations

U.S. sites
45
U.S. states
22
U.S. cities
45
Facility City State ZIP Site status
Not listed Beverly Hills California
Not listed Chino California
Not listed Lincoln California
Not listed Los Angeles California
Not listed Newport Beach California
Not listed North Hollywood California
Not listed Thousand Oaks California
Not listed Vista California
Not listed Brooksville Florida
Not listed Fort Lauderdale Florida
Not listed Jacksonville Florida
Not listed Jupiter Florida
Not listed Miami Florida
Not listed Pembroke Pines Florida
Not listed Port Orange Florida
Not listed Marietta Georgia
Not listed Meridian Idaho
Not listed Chicago Illinois
Not listed Evanston Illinois
Not listed Evansville Indiana
Not listed Indianapolis Indiana
Not listed Newton Kansas
Not listed Wichita Kansas
Not listed Auburn Maine
Not listed Elkridge Maryland
Not listed Edina Minnesota
Not listed Jackson Mississippi
Not listed Butte Montana
Not listed Las Vegas Nevada
Not listed Berlin New Jersey
Not listed Endwell New York
Not listed Rochester New York
Not listed Greensboro North Carolina
Not listed Cincinnati Ohio
Not listed Kettering Ohio
Not listed Lyndhurst Ohio
Not listed Marion Ohio
Not listed Willoughby Hills Ohio
Not listed Downingtown Pennsylvania
Not listed Charleston South Carolina
Not listed Mt. Pleasant South Carolina
Not listed Kingsport Tennessee
Not listed Houston Texas
Not listed Hurst Texas
Not listed Madison Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02670434, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 9, 2021 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02670434 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →